Phase 4 Peripheral Neuropathy Trial, Recruiting NCT06959147 Sponsor: Shirong Tan Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Phase 4 Peripheral Neuropathy Trial, Recruiting

NCT06959147
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have agreed to take part and have signed a consent form.
  • Your shingles-related nerve pain has not improved enough with medications or other non-surgical treatments, or the side effects of those treatments have been too difficult to tolerate.
  • Your shingles rash affected areas on or around your head, neck, chest, or lower back.
  • Your pain is moderate to severe, meaning it scores 4 or higher on a pain scale of 0–10.
  • You are between 40 and 85 years old.
  • You weigh at least 50 kg (about 110 lbs) if male, or at least 45 kg (about 99 lbs) if female.

Who may not be able to join:

  • You have serious heart disease or a dangerous irregular heartbeat (such as heart failure or a significant heart rhythm problem without a pacemaker).
  • You have a condition that makes minor procedures risky, such as a blood clotting disorder or an active infection.
  • You are allergic to local anaesthetics or fat-based IV solutions, or you have severe problems with your heart, lungs, liver, or kidneys that would make the procedure unsafe.
  • You have a serious hormone-related condition, or you have been taking steroid or immune-suppressing medications for a long time.
  • You have memory, thinking, or cognitive difficulties that would make it hard to follow the treatment plan.
  • You have previously had nerve-related treatments such as spinal cord stimulation or a procedure called pulsed radiofrequency (PRF).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Shirong Tan
Registry
ClinicalTrials.gov
Start date
17 December 2024
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

NRS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov